is compounded semaglutide safe for weight loss a Compound Drug Safe? Embody | Personalized GLP-1 Weight

FAQ Questions answered plainly

In Phase 2 trials, 3041% of participants discontinued antihypertensive medications during treatment

445 adults with obesity or overweight plus knee osteoarthritis, without T2D

Because systemic estrogen affects insulin sensitivity and fat distribution, it can influence the broader metabolic baseline that GLP-1 therapy interacts with

In a Phase 2 clinical trial , adults with overweight or obesity taking the lowest dose (1 mg) lost about 8.7% of their body weight on average after 48 weeks

For licensed GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) and liraglutide (Saxenda), the MHRA-approved Summaries of Product Characteristics (SmPCs) do not list testosterone as a contraindicated or interacting medicine